FAQ

Wakefulness-Promoting Agents

Known as: Wakefulness Promoting Agents, Wake Promoting Substances, Wake-Promoting Drugs 
A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2018
0246819852018

Related topics

Related topics

8 relations
In Bloodagonistsantagonists & inhibitorschemical synthesis
(More)

Narrower (2)

armodafinilmodafinil

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Wakefulness-Promoting Agents
In Blood
chemical synthesis
modafinil
standards characteristics
armodafinil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials
There is limited information available concerning the treatment of daytime somnolence associated with Parkinson's disease (PD… (More)
Is this relevant?
Review
2015
Review
2015
Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
STUDY OBJECTIVES To perform a meta-analysis of the effect of wakefulness-promoting agents (modafinil and armodafinil) in patients… (More)
Is this relevant?
2013
2013
Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure.
Hypoxic brain damage might explain persistent sleepiness in some continuous positive airway pressure-compliant obstructive sleep… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.
STUDY OBJECTIVE Rebound hypersomnolence (RHS: increased sleep following increased wake) is a limiting side-effect of many wake… (More)
Is this relevant?
2009
2009
Hemodynamic and cardiac neurotransmitter-releasing effects in conscious dogs of attention- and wake-promoting agents: a comparison of d-amphetamine, atomoxetine, modafinil, and a novel quinazolinone…
Conscious coronary sinus-cannulated dogs were used to assess the hemodynamic effects and local cardiac norepinephrine (NE) and… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
2008
2008
Does excessive daytime sleepiness contribute to explaining the association between obesity and ADHD symptoms?
Recent studies suggest a significant association between obesity and attention-deficit/hyperactivity disorder (ADHD). The factors… (More)
Is this relevant?
2007
2007
Pattern Recognition of Sleep in Rodents Using Piezoelectric Signals Generated by Gross Body Movements
Current research on sleep using experimental animals is limited by the expense and time-consuming nature of traditional EEG/EMG… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
The socioeconomic impact of narcolepsy.
STUDY OBJECTIVE To evaluate the economic burden of patients suffering from narcolepsy. DESIGN Cross-sectional study… (More)
Is this relevant?
2003
2003
Sleepiness and Unintended Sleep in Parkinson's Disease.
Patients with Parkinson's disease (PD) and parkinsonian syndromes (eg, dementia with Lewy bodies, multisystem atrophy, and Shy… (More)
Is this relevant?
2000
2000
Promoting health or promoting pleasure? A contingency approach to the effect of informational and emotional appeals on food liking and consumption.
Here, we suggest that the relative effectiveness of informational and emotional appeals in persuasive communications may depend… (More)
Is this relevant?